PACS (PACS) had the highest return between November 1, 2025 and December 31, 2025 by a mid-cap US stock, returning 217%.
| ASSET | DATE | % RETURN |
|---|---|---|
PACS (PACS) | 11/1/2025 - 12/31/2025 | 217.01% |
Hycroft Mining (HYMC) | 11/1/2025 - 12/31/2025 | 212.76% |
Cogent Biosciences (COGT) | 11/1/2025 - 12/31/2025 | 118.58% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 11/1/2025 - 12/31/2025 | 110.12% |
Sellas Life Sciences (SLS) | 11/1/2025 - 12/31/2025 | 104.89% |
AXT (AXTI) | 11/1/2025 - 12/31/2025 | 92.92% |
Vera Therapeutics (VERA) | 11/1/2025 - 12/31/2025 | 80.28% |
Abercrombie & Fitch (ANF) | 11/1/2025 - 12/31/2025 | 76.39% |
Nuvation Bio (NUVB) | 11/1/2025 - 12/31/2025 | 67.79% |
Praxis Precision Medicines (PRAX) | 11/1/2025 - 12/31/2025 | 63.3% |
ChronoScale (CHRN) | 11/1/2025 - 12/31/2025 | 62.41% |
Haemonetics (HAE) | 11/1/2025 - 12/31/2025 | 60.62% |
American Eagle Outfitters (AEO) | 11/1/2025 - 12/31/2025 | 58.76% |
Arrowhead Pharmaceuticals (ARWR) | 11/1/2025 - 12/31/2025 | 58.11% |
Aura Minerals Inc Common Shares (AUGO) | 11/1/2025 - 12/31/2025 | 57.02% |
Kodiak Sciences (KOD) | 11/1/2025 - 12/31/2025 | 54.05% |
Figs (FIGS) | 11/1/2025 - 12/31/2025 | 52.89% |
Scholar Rock (SRRK) | 11/1/2025 - 12/31/2025 | 49.88% |
McGraw Hill (MH) | 11/1/2025 - 12/31/2025 | 49.59% |
Erasca (ERAS) | 11/1/2025 - 12/31/2025 | 49.52% |
Allied Gold (AAUC) | 11/1/2025 - 12/31/2025 | 49.25% |
Nurix Therapeutics (NRIX) | 11/1/2025 - 12/31/2025 | 49.14% |
Belite Bio Inc ADR (BLTE) | 11/1/2025 - 12/31/2025 | 48.8% |
Ondas (ONDS) | 11/1/2025 - 12/31/2025 | 48.44% |
Axogen (AXGN) | 11/1/2025 - 12/31/2025 | 48.1% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.